www.prnewswire.com
Open in
urlscan Pro
2606:4700:4400::6812:21c3
Public Scan
Submitted URL: https://tracking.managedhealthcareconnect.com/?ref=bkQAAB3rWHKflxj76Xl0Jud67TOFSkx0AQAAAEM5rqbJ8erx6KwO65UAx-_PRLDVbPplQFKPpkNr8svJuWeOdupQZ6h...
Effective URL: https://www.prnewswire.com/news-releases/dariohealth-enters-into-strategic-agreement-with-sanofi-us-301492595.html
Submission: On October 18 via api from US — Scanned from DE
Effective URL: https://www.prnewswire.com/news-releases/dariohealth-enters-into-strategic-agreement-with-sanofi-us-301492595.html
Submission: On October 18 via api from US — Scanned from DE
Form analysis 1 forms found in the DOM
<form class="search-bar">
<div class="input-group">
<input type="hidden" id="sitesearchurl" name="searchlink" value="/search/all/">
<input type="hidden" id="prodsearchurl" name="prodsearchlink" value="/search/products/">
<input type="hidden" id="resourcesearchurl" name="resourcesearchlink" value="/search/resources/">
<input type="hidden" id="orgsearchurl" name="orgsearchlink" value="/search/organization/">
<input type="hidden" id="allnewssearchurl" name="allnewssearchlink" value="/search/news/">
<input type="hidden" id="enableQuickSearch" name="enableQuickSearch" value="true">
<input type="hidden" id="newsVanityPathURL" name="newsVanityPathURL" value="/news/">
<label class="search-label" id="Search">Search</label>
<span class="sr-only" id="autopoplabel">When typing in this field, a list of search results will appear and be automatically updated as you type.</span>
<input type="text" id="sitesearchbox" name="Search" aria-describedby="autopoplabel" autocomplete="off" class="form-control form-search" placeholder="Search News Releases, Organizations, Resources, and Products"
aria-label="Search News Releases, Organizations, Resources, and Products">
</div>
<div class="qs-error">
</div>
</form>Text Content
Close menu
NewsProductsContact
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* 3 News in Focus
* 5 Business & Money
* 5 Science & Tech
* 5 Lifestyle & Health
* 0 Policy & Public Interest
* 1 People & Culture
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* Overview
* Distribution by PR Newswire
* Cision Communications Cloud®
* Cision IR
* All Products
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
Close submenu (News in Focus)News in Focus
* Browse All News
* Multimedia Gallery
* Trending Topics
Close submenu (Business & Money)Business & Money
* Auto & Transportation
* Business Technology
* Entertainment & Media
* Financial Services & Investing
* General Business
Close submenu (Science & Tech)Science & Tech
* Consumer Technology
* Energy & Natural Resources
* Environment
* Heavy Industry & Manufacturing
* Telecommunications
Close submenu (Lifestyle & Health)Lifestyle & Health
* Consumer Products & Retail
* Entertainment & Media
* Health
* Sports
* Travel
Close submenu (Policy & Public Interest)Policy & Public Interest
Close submenu (People & Culture)People & Culture
* People & Culture
* Resources
* Blog
* Journalists
* Log In
* Sign Up
* Data Privacy
* Send a Release
* News
* Products
* Contact
Search
Search When typing in this field, a list of search results will appear and be
automatically updated as you type.
Searching for your content...
No results found. Please change your search terms and try again.
* News in Focus
* * BROWSE NEWS RELEASES
* All News Releases
* All Public Company
* English-only
* NEWS RELEASES OVERVIEW
* MULTIMEDIA GALLERY
* All Multimedia
* All Photos
* All Videos
* MULTIMEDIA GALLERY OVERVIEW
* TRENDING TOPICS
* All Trending Topics
* Business & Money
* * AUTO & TRANSPORTATION
* All Automotive & Transportation
* Aerospace, Defense
* Air Freight
* Airlines & Aviation
* Automotive
* Maritime & Shipbuilding
* Railroads and Intermodal Transportation
* Supply Chain/Logistics
* Transportation, Trucking & Railroad
* Travel
* Trucking and Road Transportation
* AUTO & TRANSPORTATION OVERVIEW
* VIEW ALL AUTO & TRANSPORTATION
* BUSINESS TECHNOLOGY
* All Business Technology
* Blockchain
* Broadcast Tech
* Computer & Electronics
* Computer Hardware
* Computer Software
* Data Analytics
* Electronic Commerce
* Electronic Components
* Electronic Design Automation
* Financial Technology
* High Tech Security
* Internet Technology
* Nanotechnology
* Networks
* Peripherals
* Semiconductors
* BUSINESS TECHNOLOGY OVERVIEW
* VIEW ALL BUSINESS TECHNOLOGY
* ENTERTAINMENT & MEDIA
* All Entertainment & Media
* Advertising
* Art
* Books
* Entertainment
* Film and Motion Picture
* Magazines
* Music
* Publishing & Information Services
* Radio & Podcast
* Television
* ENTERTAINMENT & MEDIA OVERVIEW
* VIEW ALL ENTERTAINMENT & MEDIA
* FINANCIAL SERVICES & INVESTING
* All Financial Services & Investing
* Accounting News & Issues
* Acquisitions, Mergers and Takeovers
* Banking & Financial Services
* Bankruptcy
* Bond & Stock Ratings
* Conference Call Announcements
* Contracts
* Cryptocurrency
* Dividends
* Earnings
* Earnings Forecasts & Projections
* Financing Agreements
* Insurance
* Investments Opinions
* Joint Ventures
* Mutual Funds
* Private Placement
* Real Estate
* Restructuring & Recapitalization
* Sales Reports
* Shareholder Activism
* Shareholder Meetings
* Stock Offering
* Stock Split
* Venture Capital
* FINANCIAL SERVICES & INVESTING OVERVIEW
* VIEW ALL FINANCIAL SERVICES & INVESTING
* GENERAL BUSINESS
* All General Business
* Awards
* Commercial Real Estate
* Corporate Expansion
* Earnings
* Environmental, Social and Governance (ESG)
* Human Resource & Workforce Management
* Licensing
* New Products & Services
* Obituaries
* Outsourcing Businesses
* Overseas Real Estate (non-US)
* Personnel Announcements
* Real Estate Transactions
* Residential Real Estate
* Small Business Services
* Socially Responsible Investing
* Surveys, Polls and Research
* Trade Show News
* GENERAL BUSINESS OVERVIEW
* VIEW ALL GENERAL BUSINESS
* Science & Tech
* * CONSUMER TECHNOLOGY
* All Consumer Technology
* Artificial Intelligence
* Blockchain
* Cloud Computing/Internet of Things
* Computer Electronics
* Computer Hardware
* Computer Software
* Consumer Electronics
* Cryptocurrency
* Data Analytics
* Electronic Commerce
* Electronic Gaming
* Financial Technology
* Mobile Entertainment
* Multimedia & Internet
* Peripherals
* Social Media
* STEM (Science, Tech, Engineering, Math)
* Supply Chain/Logistics
* Wireless Communications
* CONSUMER TECHNOLOGY OVERVIEW
* VIEW ALL CONSUMER TECHNOLOGY
* ENERGY & NATURAL RESOURCES
* All Energy
* Alternative Energies
* Chemical
* Electrical Utilities
* Gas
* General Manufacturing
* Mining
* Mining & Metals
* Oil & Energy
* Oil and Gas Discoveries
* Utilities
* Water Utilities
* ENERGY & NATURAL RESOURCES OVERVIEW
* VIEW ALL ENERGY & NATURAL RESOURCES
* ENVIRONMENT
* All Environment
* Conservation & Recycling
* Environmental Issues
* Environmental Policy
* Environmental Products & Services
* Green Technology
* Natural Disasters
* ENVIRONMENT OVERVIEW
* VIEW ALL ENVIRONMENT
* HEAVY INDUSTRY & MANUFACTURING
* All Heavy Industry & Manufacturing
* Aerospace & Defense
* Agriculture
* Chemical
* Construction & Building
* General Manufacturing
* HVAC (Heating, Ventilation and Air-Conditioning)
* Machinery
* Machine Tools, Metalworking and Metallurgy
* Mining
* Mining & Metals
* Paper, Forest Products & Containers
* Precious Metals
* Textiles
* Tobacco
* HEAVY INDUSTRY & MANUFACTURING OVERVIEW
* VIEW ALL HEAVY INDUSTRY & MANUFACTURING
* TELECOMMUNICATIONS
* All Telecommunications
* Carriers and Services
* Mobile Entertainment
* Networks
* Peripherals
* Telecommunications Equipment
* Telecommunications Industry
* VoIP (Voice over Internet Protocol)
* Wireless Communications
* TELECOMMUNICATIONS OVERVIEW
* VIEW ALL TELECOMMUNICATIONS
* Lifestyle & Health
* * CONSUMER PRODUCTS & RETAIL
* All Consumer Products & Retail
* Animals & Pets
* Beers, Wines and Spirits
* Beverages
* Bridal Services
* Cannabis
* Cosmetics and Personal Care
* Fashion
* Food & Beverages
* Furniture and Furnishings
* Home Improvement
* Household, Consumer & Cosmetics
* Household Products
* Jewelry
* Non-Alcoholic Beverages
* Office Products
* Organic Food
* Product Recalls
* Restaurants
* Retail
* Supermarkets
* Toys
* CONSUMER PRODUCTS & RETAIL OVERVIEW
* VIEW ALL CONSUMER PRODUCTS & RETAIL
* ENTERTAINMENT & MEDIA
* All Entertainment & Media
* Advertising
* Art
* Books
* Entertainment
* Film and Motion Picture
* Magazines
* Music
* Publishing & Information Services
* Radio & Podcast
* Television
* ENTERTAINMENT & MEDIA OVERVIEW
* VIEW ALL ENTERTAINMENT & MEDIA
* HEALTH
* All Health
* Biometrics
* Biotechnology
* Clinical Trials & Medical Discoveries
* Dentistry
* FDA Approval
* Fitness/Wellness
* Health Care & Hospitals
* Health Insurance
* Infection Control
* International Medical Approval
* Medical Equipment
* Medical Pharmaceuticals
* Mental Health
* Pharmaceuticals
* Supplementary Medicine
* HEALTH OVERVIEW
* VIEW ALL HEALTH
* SPORTS
* All Sports
* General Sports
* Outdoors, Camping & Hiking
* Sporting Events
* Sports Equipment & Accessories
* SPORTS OVERVIEW
* VIEW ALL SPORTS
* TRAVEL
* All Travel
* Amusement Parks and Tourist Attractions
* Gambling & Casinos
* Hotels and Resorts
* Leisure & Tourism
* Outdoors, Camping & Hiking
* Passenger Aviation
* Travel Industry
* TRAVEL OVERVIEW
* VIEW ALL TRAVEL
* Policy & Public Interest
* * POLICY & PUBLIC INTEREST
* All Policy & Public Interest
* Advocacy Group Opinion
* Animal Welfare
* Congressional & Presidential Campaigns
* Corporate Social Responsibility
* Domestic Policy
* Economic News, Trends, Analysis
* Education
* Environmental
* European Government
* FDA Approval
* Federal and State Legislation
* Federal Executive Branch & Agency
* Foreign Policy & International Affairs
* Homeland Security
* Labor & Union
* Legal Issues
* Natural Disasters
* Not For Profit
* Patent Law
* Public Safety
* Trade Policy
* U.S. State Policy
* POLICY & PUBLIC INTEREST OVERVIEW
* VIEW ALL POLICY & PUBLIC INTEREST
* People & Culture
* * PEOPLE & CULTURE
* All People & Culture
* Aboriginal, First Nations & Native American
* African American
* Asian American
* Children
* Diversity, Equity & Inclusion
* Hispanic
* Lesbian, Gay & Bisexual
* Men's Interest
* People with Disabilities
* Religion
* Senior Citizens
* Veterans
* Women
* PEOPLE & CULTURE OVERVIEW
* VIEW ALL PEOPLE & CULTURE
* In-Language News
* español
* português
* Česko
* Danmark
* Deutschland
* España
* France
* Italia
* Nederland
* Norge
* Polska
* Portugal
* Россия
* Slovensko
* Suomi
* Sverige
* Overview
* Distribution by PR Newswire
* Cision Communications Cloud®
* Cision IR
* Sponsored Placement
* All Products
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
*
*
* Send a Release
*
* * ALL CONTACT INFO
* Contact Us
888-776-0942
from 8 AM - 10 PM ET
*
* *
DARIOHEALTH ENTERS INTO STRATEGIC AGREEMENT WITH SANOFI U.S.
USA - ENGLISH
* USA - ENGLISH
Novel Strategic Agreement Focuses on Commercial Growth for Dario and the
Development of Digital Health Solutions on Dario's Platform
--------------------------------------------------------------------------------
News provided by
DarioHealth Corp.
Mar 01, 2022, 07:05 ET
SHARE THIS ARTICLE
Share this article
--------------------------------------------------------------------------------
NEW YORK, March 1, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a
leader in the global digital therapeutics (DTx) market, announced it has entered
into a strategic agreement with Sanofi U.S., an innovative global healthcare
company. The multi-year, $30 million-dollar agreement, which is subject to
certain contingencies, will help accelerate commercial adoption of Dario's full
suite of digital therapeutics and drive the expansion of digital health
solutions on the Dario platform.
Dario and Sanofi will collaborate on promoting the Dario multi-condition digital
therapeutics solution, significantly increasing Dario's sales reach in the
health plan market and selectively in the employer channel. In addition, the
agreement calls for Dario and Sanofi to develop new or enhanced solutions
leveraging the Dario platform, and for the parties to generate robust evidence
to support future commercialization in the health plan channel.
Sanofi selected Dario to leverage its broad suite of digital therapeutics and
its ability to engage patients for favorable clinical and financial outcomes, as
the solution of choice for its U.S. commercial clients. Dario's single platform
helps patients manage diabetes, hypertension, weight management, musculoskeletal
and behavioral health, offering Sanofi managed care clients an attractive,
easily scalable digital health solution that creates immediate access across a
wide range of needs.
"We are thrilled to be chosen by Sanofi to expand into the digital health
market. We believe that this is the first time that a large biopharmaceutical
company and a digital health company are collaborating to commercialize digital
health solutions in the U.S. market. Dario's proven digital therapeutic
solutions and innovative technologies provide the perfect complement to Sanofi's
scientific expertise, market access and scale, creating a foundation for
long-term success in support of Sanofi's goal of expanding into digital health
therapies for chronic conditions," said Erez Raphael, CEO, DarioHealth.
"Our collaboration with Dario is another step towards accelerating Sanofi's
mission of reversing the course of chronic diseases through the integration of
healthcare and technology in a way that gives people the tools to improve their
health," said Gustavo Pesquin, Head, U.S. General Medicines, Sanofi. "We are
excited to help payers realize the potential digital health can bring to the
patient experience, and we look forward to continuing to innovate with Dario on
the next generation of chronic condition therapies."
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics
company revolutionizing how people with chronic conditions manage their health.
DarioHealth offers one of the most comprehensive digital therapeutics solutions
on the market - covering multiple chronic conditions including diabetes,
hypertension, weight management, musculoskeletal and behavioral health within
one integrated technology platform.
Dario's next-generation, AI-powered, digital therapeutic platform supports more
than just an individual's disease. Dario provides adaptive, personalized
experiences that drive behavior change through evidence-based interventions,
intuitive, clinically proven digital tools, high-quality software, and coaching
to help individuals improve health and sustain meaningful outcomes.
Dario's unique user-centric approach to product design and engagement creates an
unparalleled experience that is highly rated by users and delivers sustainable
results.
The company's cross-functional team operates at the intersection of life
sciences, behavioral science, and software technology and utilizes a
performance-based approach to improve its users' health.
On the path to better health, Dario makes the right thing to do the easy thing
to do. To learn more about DarioHealth and its digital health solutions or for
more information, visit http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of
DarioHealth Corp. related thereto contain or may contain forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995. Statements that are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using forward-looking
statements in this press release when it discusses the potential value of the
agreement and that the agreement will help accelerate commercial adoption of
Dario's full suite of digital therapeutics and drive the expansion of digital
health solutions on the Dario platform, the benefits that may be realized by the
Dario solution and that the collaboration creates the foundation for long-term
success in support of Sanofi's goal of expanding into digital health therapies
for chronic conditions. Without limiting the generality of the foregoing, words
such as "plan," "project," "potential," "seek," "may," "will," "expect,"
"believe," "anticipate," "intend," "could," "estimate" or "continue" are
intended to identify forward-looking statements. Readers are cautioned that
certain important factors may affect the Company's actual results and could
cause such results to differ materially from any forward-looking statements that
may be made in this news release. Factors that may affect the Company's results
include, but are not limited to, regulatory approvals, product demand, market
acceptance, impact of competitive products and prices, product development,
commercialization or technological difficulties, the success or failure of
negotiations and trade, legal, social and economic risks, and the risks
associated with the adequacy of existing cash resources. Additional factors that
could cause or contribute to differences between the Company's actual results
and forward-looking statements include, but are not limited to, those risks
discussed in the Company's filings with the U.S. Securities and Exchange
Commission. Readers are cautioned that actual results (including, without
limitation, the timing for and results of the Company's commercial and
regulatory plans for Dario™ as described herein) may differ significantly from
those set forth in the forward-looking statements. The Company undertakes no
obligation to publicly update any forward-looking statements, whether as a
result of new information, future events or otherwise, except as required by
applicable law.
DarioHealth Corporate Contact
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220
Media Contact:
Josephine Galatioto
Josephine.Galatioto@russopartnersllc.com
+1-212-845-4262
SOURCE DarioHealth Corp.
×
MODAL TITLE
ALSO FROM THIS SOURCE
DARIO'S FULL SUITE OF DIGITAL SOLUTIONS SELECTED BY MIDWESTERN...
--------------------------------------------------------------------------------
DARIOHEALTH PUBLISHES NEW CLINICAL RESEARCH LINKING THE USE OF...
EXPLORE
More news releases in similar topics
* Health Care & Hospitals
* Medical Pharmaceuticals
* Computer Software
* Computer & Electronics
* Data Analytics
CONTACT CISION
* Cision Distribution 888-776-0942
from 8 AM - 9 PM ET
* Chat with an Expert
Contact Us
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
PRODUCTS
* Cision Communication Cloud®
* For Marketers
* For Public Relations
* For IR & Compliance
* For Agency
* For Small Business
* All Products
ABOUT
* About PR Newswire
* About Cision
* Become a Publishing Partner
* Become a Channel Partner
* Careers
* COVID-19 Resources
* Accessibility Statement
Global Sites
* Asia
* Brazil
* Canada
* Czech
* Denmark
* Finland
* France
* Germany
* India
* Israel
* Italy
* Mexico
* Middle East
* Netherlands
* Norway
* Poland
* Portugal
* Russia
* Slovakia
* Spain
* Sweden
* United Kingdom
MY SERVICES
* All New Releases
* Online Member Center
* ProfNet
CONTACT CISION
PRODUCTS
ABOUT
My Services
* All News Releases
* Online Member Center
* ProfNet
Cision Distribution Helpline
888-776-0942
* Terms of Use
* Privacy Policy
* Information Security Policy
* Site Map
* RSS
* Cookie Settings
Copyright © 2022 Cision US Inc.
PRIVACY PREFERENCE CENTER
When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer. More information
Allow All
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY
Always Active
These technologies are needed to enable our websiteto run and keep it secure.
PERFORMANCE ANALYTICS
Performance Analytics
These technologies tell us how you use our sites and apps, and provide
information to help us improve the website and browser experience.
FUNCTIONAL
Functional
These technologies allow us to provide enhanced functionality and personalise
content for you. For example they're used to recognise you when you return to
our website. If you do not allow these technologies then some or all these
services may not function properly.
MARKETING
Marketing
These services helps us decide which products, services and content may be
relevant for you. We use this data to customise the content you see on our
websites and social media. These technologies are set by us or by our
carefully-selected third parties. They help us understand the performance of our
marketing activities and improve the relevance of the content that you see.
BACK BUTTON PERFORMANCE COOKIES
Vendor Search Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Reject All Confirm My Choices
By clicking “Accept All Cookies”, you agree to the storing of cookies on your
device to enhance site navigation, analyze site usage, and assist in our
marketing efforts.
Reject All Accept All Cookies
Cookies Settings